Julia E Inglis1, Amber S Kleckner2, Po-Ju Lin2, Nikesha J Gilmore2, Eva Culakova2, Amy C VanderWoude3, Karen M Mustian2, I Diana Fernandez4, Richard F Dunne5, Jeremy Deutsch6, Luke J Peppone2. 1. Department of Public and Community Health, Liberty University, Lynchburg, VA, USA. 2. Department of Surgery, University of Rochester Medical Center (URMC), Rochester, NY, USA. 3. Cancer Research Consortium of West Michigan, Grand Rapids, MI, USA. 4. Department of Public Health Sciences, University of Rochester Medical Center (URMC), Rochester, NY, USA. 5. Department of Medicine, University of Rochester Medical Center (URMC), Rochester, NY, USA. 6. Cancer Center of Kansas, Wichita, KS, USA.
Abstract
BACKGROUND: Cancer-related fatigue (CRF) is a common side effect impacting breast cancer survivors. Research points to a relationship between obesity and CRF in breast cancer survivors related to elevated systemic inflammation and metabolic alterations. METHODS: This cross-sectional study examined the relationship of obesity to CRF, inflammatory markers and serum lipids through a secondary analysis of a nationwide randomized controlled trial. Breast cancer survivors with CRF were categorized based on BMI category. Symptoms of CRF, inflammatory markers and serum fatty acids were assessed among groups. RESULTS: There were 105 breast cancer survivors in the analysis. BMI was positively associated with CRF based on MFSI General (p = 0.020; 95% C.I. 0.024, 0.273) and MFSI Physical (p = 0.013; 95% C.I. 0.035, 0.298) subscales. TNF-α (p = 0.007; 95% C.I. 0.007, 0.044), and IL-6 (p = 0.020; 95% C.I. 0.006, 0.073) were elevated in the obese. Monounsaturated fatty acid levels (p = 0.047; 95% C.I. 0.000, 0.053) and the omega-6 to omega-3 fatty acid ratio were associated with obesity (p = 0.047; 95% C.I. 0.002, 0.322). CONCLUSIONS: Obese breast cancer survivors had greater levels of CRF, inflammatory markers and certain fatty acids. Inflammatory markers and fatty acids were not found to have any mediating or positive association with CRF variables in this analysis. NCT02352779.
BACKGROUND: Cancer-related fatigue (CRF) is a common side effect impacting breast cancer survivors. Research points to a relationship between obesity and CRF in breast cancer survivors related to elevated systemic inflammation and metabolic alterations. METHODS: This cross-sectional study examined the relationship of obesity to CRF, inflammatory markers and serum lipids through a secondary analysis of a nationwide randomized controlled trial. Breast cancer survivors with CRF were categorized based on BMI category. Symptoms of CRF, inflammatory markers and serum fatty acids were assessed among groups. RESULTS: There were 105 breast cancer survivors in the analysis. BMI was positively associated with CRF based on MFSI General (p = 0.020; 95% C.I. 0.024, 0.273) and MFSI Physical (p = 0.013; 95% C.I. 0.035, 0.298) subscales. TNF-α (p = 0.007; 95% C.I. 0.007, 0.044), and IL-6 (p = 0.020; 95% C.I. 0.006, 0.073) were elevated in the obese. Monounsaturated fatty acid levels (p = 0.047; 95% C.I. 0.000, 0.053) and the omega-6 to omega-3 fatty acid ratio were associated with obesity (p = 0.047; 95% C.I. 0.002, 0.322). CONCLUSIONS: Obese breast cancer survivors had greater levels of CRF, inflammatory markers and certain fatty acids. Inflammatory markers and fatty acids were not found to have any mediating or positive association with CRF variables in this analysis. NCT02352779.
Authors: Julia E Inglis; Michelle C Janelsins; Eva Culakova; Karen M Mustian; Po-Ju Lin; Ian R Kleckner; Luke J Peppone Journal: Support Care Cancer Date: 2019-07-02 Impact factor: 3.603
Authors: Puneeta Tandon; K Rajender Reddy; Jacqueline G O'Leary; Guadalupe Garcia-Tsao; Juan G Abraldes; Florence Wong; Scott W Biggins; Benedict Maliakkal; Michael B Fallon; Ram M Subramanian; Paul Thuluvath; Patrick S Kamath; Leroy R Thacker; Jasmohan S Bajaj Journal: Hepatology Date: 2016-11-29 Impact factor: 17.425
Authors: Maria Azrad; Cindy K Blair; Cheryl L Rock; Rebecca L Sedjo; Kathleen Y Wolin; Wendy Demark-Wahnefried Journal: Breast Cancer Res Treat Date: 2019-05-09 Impact factor: 4.872
Authors: Amber S Kleckner; Edwin van Wijngaarden; Todd A Jusko; Ian R Kleckner; Po-Ju Lin; Karen M Mustian; Luke J Peppone Journal: Cancer Res Commun Date: 2022-03-31
Authors: Mostefa Fodil; Vincent Blanckaert; Lionel Ulmann; Virginie Mimouni; Benoît Chénais Journal: Int J Environ Res Public Health Date: 2022-06-28 Impact factor: 4.614
Authors: Amber S Kleckner; Eva Culakova; Ian R Kleckner; Elizabeth K Belcher; Wendy Demark-Wahnefried; Elizabeth A Parker; Gilbert D A Padula; Mary Ontko; Michelle C Janelsins; Karen M Mustian; Luke J Peppone Journal: Nutrients Date: 2021-12-31 Impact factor: 5.717
Authors: Antonio Di Meglio; Elise Martin; Tracy E Crane; Cecile Charles; Aude Barbier; Bruno Raynard; Anthony Mangin; Olivier Tredan; Carole Bouleuc; Paul H Cottu; Laurence Vanlemmens; Carine Segura-Djezzar; Anne Lesur; Barbara Pistilli; Florence Joly; Thomas Ginsbourger; Bernadette Coquet; Iris Pauporte; Guillemette Jacob; Aude Sirven; Julia Bonastre; Jennifer A Ligibel; Stefan Michiels; Ines Vaz-Luis Journal: Trials Date: 2022-03-04 Impact factor: 2.279
Authors: Sameer Badri Al-Mhanna; Wan Syaheedah Wan Ghazali; Mahaneem Mohamed; Ali A Rabaan; Eman Y Santali; Jeehan H Alestad; Enas Y Santali; Sohaib Arshad; Naveed Ahmed; Hafeez Abiola Afolabi Journal: PeerJ Date: 2022-08-02 Impact factor: 3.061
Authors: Molly Ream; Estefany Saez-Clarke; Chloe Taub; Alain Diaz; Daniela Frasca; Bonnie B Blomberg; Michael H Antoni Journal: Front Biosci (Landmark Ed) Date: 2022-05-07